National Formulary of India lists drugs not approved by CDSCO, DCGI seeks explanation from IPC
The National Formulary of India released its latest edition amidst concerns regarding unapproved drugs included in it. The Drug Controller General of India has communicated with the Indian Pharmacopoeia Commission regarding this discrepancy. Several drugs listed in NFI 2026 have not received approval from the Central Drugs Standard Control Organisation. Stakeholders have also raised complaints about the unavailability of the online version of NFI 2026.
RSS News
Economic times
0 thoughts on “National Formulary of India lists drugs not approved by CDSCO, DCGI seeks explanation from IPC”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Madhoo backs Rashmika Mandanna over South Indian accent criticism; says ‘own it, girl’
- Ayushmann Khurrana about an early rejection story involving Karan Johar
- Saiee M Manjrekar’s look from Ram Charan-backed ‘The India House’ leaks
- Kamal reveals how Mammootty’s joke led to ‘Mazhayethum Munpe’
- Student sets mehndi record in Karnataka
